ABCSG 18: monoclonal antibody increases disease-free survival in breast cancer

[News]

Giving a monoclonal antibody (denosumab) as adjuvant therapy with aromatase inhibitors in postmenopausal, hormone-receptor-positive breast cancer patients reduces the relapse rate by 18%.

More... (http://www.medicalnewstoday.com/releases/303917.php)